Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.82 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.82 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Isobutyl Ketone SCHEMBL1580340 | 0.91 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL15458 | 0.91 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL1128055 | 0.91 | ALDH1A1 (1.00) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL10486773 | 0.88 | ALDH1A1 (0.82) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL5712313 | 0.88 | ALDH1A1 (0.82) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL7073455 | 0.88 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL358566 | 0.88 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL6387945 | 0.88 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL2188913 | 0.88 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL809423 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240176238-A1 | SULFONIUM SALT, RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| CN-109956941-B | Simple preparation method of abamectin | 新发药业有限公司 | 2020-08-04 | — | — | CN | disclosed |
| CN-109956941-A | A kind of simple and convenient process for preparing of AVM hereinafter Batan | 新发药业有限公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-108026055-A | 2,4,6- tri-（2- hydroxy-3-methyl -4- alkoxyl phenyls）- 1,3,5- triaizine compounds and 2,4,6- tri-（2,4- dihydroxy -3- aminomethyl phenyls）The manufacture method of -1,3,5- triazines | 株式会社钟化 | 2018-05-11 | — | — | CN | disclosed |
| CN-107428672-A | The mixture and its manufacture method of polymerizable compound | 日本瑞翁株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-105492499-B | Polyarylene sulfide resin, process for producing the same, and molded article | DIC株式会社 | 2017-08-08 | — | — | CN | disclosed |
| US-20140187473-A1 | Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members | STRYKER CORPORATION (US) | 2014-07-03 | — | — | US | disclosed |
| US-8535869-B2 | Sulfonium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| US-20120045724-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-0601288-B1 | Substituted 2,3-dicarboxypyridinium nitrates | BASF AG (DE) | 2003-05-02 | — | — | EP | disclosed |
| US-5410062-A | Heating substituted quinoline with nitric acid in presence of manganese catalyst, concentrating in presence of nitroaromatic solvent | AMERICAN CYANAMID COMPANY (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0601288-A2 | Substituted 2,3-dicarboxypyridinium nitrates | AMERICAN CYANAMID COMPANY (US) | 1994-06-15 | — | — | EP | disclosed |
| US-5284955-A | Herbicide intermediates | AMERICAN CYANAMID COMPANY (US) | 1994-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240176238-A1 | SULFONIUM SALT, RESIST COMPOSITION AND PATTERN FORMING PROCESS | SLC6A5, HNRNPU, SLC6A9 | ALDH1A1 4876/4885TDP1 3161/4885CA2 18/4885 |
| US-20120045724-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SLC6A5, NES, STS | ALDH1A1 3412/4885TDP1 3654/4885CA2 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.